ArticleCureus2026

Add-On Spironolactone for Persistent Proteinuria After Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Patients With Diabetic Kidney Disease: A Retrospective Observational Study.

Seigo Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.